Thrivent Financial for Lutherans Sells 1,040 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Thrivent Financial for Lutherans decreased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 5.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,366 shares of the medical instruments supplier's stock after selling 1,040 shares during the period. Thrivent Financial for Lutherans owned approximately 0.08% of Mettler-Toledo International worth $21,251,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MTD. JPMorgan Chase & Co. increased its stake in shares of Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after acquiring an additional 28,478 shares during the period. M&T Bank Corp increased its position in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock valued at $7,387,000 after purchasing an additional 615 shares during the period. Allworth Financial LP raised its stake in shares of Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after buying an additional 169 shares in the last quarter. Nordea Investment Management AB lifted its holdings in shares of Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock valued at $129,919,000 after buying an additional 24,285 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its stake in Mettler-Toledo International by 18.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after buying an additional 5,234 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several brokerages have commented on MTD. Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Wolfe Research began coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a "peer perform" rating on the stock. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an "equal weight" rating in a research note on Monday, February 10th. Finally, Citigroup cut their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $1,380.50.

Mettler-Toledo International Stock Performance

Shares of MTD stock traded up $12.50 on Monday, reaching $1,211.71. 121,602 shares of the company's stock traded hands, compared to its average volume of 127,600. The company has a market capitalization of $25.25 billion, a P/E ratio of 29.90, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12-month low of $1,142.91 and a 12-month high of $1,546.93. The business's 50 day moving average price is $1,291.57 and its two-hundred day moving average price is $1,308.45.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christian Magloth sold 790 shares of the business's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.